Emma Reeve

Emma Reeve currently serves as Independent Director at PTC Therapeutics, Inc. since 2018, Director at Ribon Therapeutics, Inc. since 2020, Independent Director at Cardurion Pharmaceuticals, Inc. since 2023, Director at Aadi Subsidiary, Inc. since 2021, Independent Director at Whitehawk Therapeutics, Inc. since 2021, Associate at The Institute of Chartered Accountants in England & Wales, and Trustee at Tufts Medical Center, Inc. Former roles include Chairman at Editas Medicine, Inc. from 2023 to 2024, Senior Director-Research Operations at Merck Research Laboratories Massachusetts LLC from 2004 to 2006, Director at Novitas Loans Ltd., Assistant Controller at Bristol Myers Squibb Co. from 1994 to 2002, Chief Financial Officer & Vice President at PAREXEL International Corp.
in 2017, Chief Financial Officer at Inotek Pharmaceuticals Corp.
from 2006 to 2007, Head-Finance & Administration at Novartis Pharma Schweiz AG from 2012 to 2014, Chief Financial Officer at Aton Pharma, Inc. from 2002 to 2004, Chief Financial Officer, Treasurer & Senior VP at Constellation Pharmaceuticals, Inc. from 2018 to 2021, and Head-Business Planning & Analysis at Novartis Vaccines & Diagnostics SAS from 2008 to 2012.
Education includes undergraduate studies at Imperial College London.